• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重链的长互补决定区3在广泛中和抗人类免疫缺陷病毒1型抗体2F5的活性中起重要作用。

The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.

作者信息

Zwick Michael B, Komori H Kiyomi, Stanfield Robyn L, Church Sarah, Wang Meng, Parren Paul W H I, Kunert Renate, Katinger Hermann, Wilson Ian A, Burton Dennis R

机构信息

Department of Immunology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA.

出版信息

J Virol. 2004 Mar;78(6):3155-61. doi: 10.1128/jvi.78.6.3155-3161.2004.

DOI:10.1128/jvi.78.6.3155-3161.2004
PMID:14990736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC353725/
Abstract

The human monoclonal antibody 2F5 neutralizes primary human immunodeficiency virus type 1 (HIV-1) with rare breadth and potency. A crystal structure of a complex of 2F5 and a peptide corresponding to its core epitope on gp41, ELDKWAS, revealed that the peptide interacts with residues at the base of the unusually long (22-residue) third complementarity-determining region of the heavy chain (CDR H3) but not the apex. Here, we perform alanine-scanning mutagenesis across CDR H3 and make additional substitutions of selected residues to map the paratope of Fab 2F5. Substitution of residues from the base of the H3 loop or from CDRs H1, H2, and L3, which are proximal to the peptide, significantly diminished the affinity of Fab 2F5 for gp41 and a short peptide containing the 2F5 core motif. However, nonconservative substitutions to a phenylalanine residue at the apex of the H3 loop also markedly decreased 2F5 binding to both gp41 and the peptide, suggesting that recognition of the core epitope is crucially dependent on features at the apex of the H3 loop. Furthermore, substitution at the apex of the H3 loop had an even more pronounced effect on the neutralizing activity of 2F5 against three sensitive HIV-1. These observations present a challenge to vaccine strategies based on peptide mimics of the linear epitope.

摘要

人源单克隆抗体2F5能以罕见的广度和效力中和1型原发性人类免疫缺陷病毒(HIV-1)。2F5与gp41上对应其核心表位ELDKWAS的肽段形成的复合物的晶体结构显示,该肽段与重链异常长(22个残基)的第三互补决定区(CDR H3)基部的残基相互作用,而非顶端。在此,我们对CDR H3进行丙氨酸扫描诱变,并对选定残基进行额外替换,以绘制Fab 2F5的抗原结合位点图谱。替换H3环基部或与该肽段相邻的CDR H1、H2和L3中的残基,显著降低了Fab 2F5对gp41和包含2F5核心基序的短肽的亲和力。然而,将H3环顶端的一个残基非保守替换为苯丙氨酸也显著降低了2F5与gp41和该肽段的结合,这表明对核心表位的识别关键取决于H3环顶端的特征。此外,H3环顶端的替换对2F5针对三种敏感HIV-1的中和活性有更显著的影响。这些观察结果对基于线性表位肽模拟物的疫苗策略提出了挑战。

相似文献

1
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.重链的长互补决定区3在广泛中和抗人类免疫缺陷病毒1型抗体2F5的活性中起重要作用。
J Virol. 2004 Mar;78(6):3155-61. doi: 10.1128/jvi.78.6.3155-3161.2004.
2
Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.抗 HIV-1 广泛中和抗体 2F5 的互补决定区 H3 顶端的消融消除了中和能力而不影响核心表位结合。
J Virol. 2010 May;84(9):4136-47. doi: 10.1128/JVI.02357-09. Epub 2010 Feb 10.
3
Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.抗1型HIV抗体2F5与磷脂双层的相互作用及其与病毒中和机制的相关性。
AIDS Res Hum Retroviruses. 2011 Aug;27(8):863-76. doi: 10.1089/AID.2010.0265. Epub 2011 Jan 15.
4
Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.交叉中和抗HIV-1抗体2F5的F(ab)'片段与其抗独特型抗体3H6的F(ab)片段之间复合物的晶体结构。
J Mol Biol. 2008 Oct 17;382(4):910-9. doi: 10.1016/j.jmb.2008.07.057. Epub 2008 Jul 27.
5
Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.广谱中和单克隆抗体2F5识别HIV-1的结构细节:表位构象、抗原识别环的灵活性及阴离子结合位点
J Mol Biol. 2008 Dec 12;384(2):377-92. doi: 10.1016/j.jmb.2008.09.024. Epub 2008 Sep 18.
6
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.2F5 样抗体 m66 和 m66.6 对 HIV-1 中和作用的结构基础
J Virol. 2014 Mar;88(5):2426-41. doi: 10.1128/JVI.02837-13. Epub 2013 Dec 11.
7
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.抗人免疫缺陷病毒1型抗体2F5与其gp41表位复合物的结构及机制分析
J Virol. 2004 Oct;78(19):10724-37. doi: 10.1128/JVI.78.19.10724-10737.2004.
8
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.一种针对人类免疫缺陷病毒1型gp41膜近端外部区域的亲和力增强型中和抗体识别的表位介于2F5和4E10的表位之间。
J Virol. 2007 Apr;81(8):4033-43. doi: 10.1128/JVI.02588-06. Epub 2007 Feb 7.
9
Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.结构导向的 HIV-1 广谱中和抗体 2F5 的改变揭示了其中和功能的新特性。
PLoS Pathog. 2012;8(7):e1002806. doi: 10.1371/journal.ppat.1002806. Epub 2012 Jul 19.
10
Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.识别1型人类免疫缺陷病毒gp120所需的广泛中和性免疫球蛋白G1 b12的分子特征
J Virol. 2003 May;77(10):5863-76. doi: 10.1128/jvi.77.10.5863-5876.2003.

引用本文的文献

1
Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations.通过多尺度模拟对HIV-1 MPER抗体的特定磷脂复合物和膜结合进行从头预测。
Elife. 2025 Apr 7;12:RP90139. doi: 10.7554/eLife.90139.
2
Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility.Fab 进入的结构约束不足而非中和表位诱导限制了 HIV-1 MPER 疫苗的应用。
Nat Commun. 2023 Nov 8;14(1):7218. doi: 10.1038/s41467-023-42097-6.
3
Broadly neutralizing antibodies targeting HIV: Progress and challenges.广谱中和抗体靶向 HIV:进展与挑战。
Clin Immunol. 2023 Dec;257:109809. doi: 10.1016/j.clim.2023.109809. Epub 2023 Oct 16.
4
Characterization of human IgM and IgG repertoires in individuals with chronic HIV-1 infection.鉴定慢性 HIV-1 感染个体的人 IgM 和 IgG 库。
Virol Sin. 2022 Jun;37(3):370-379. doi: 10.1016/j.virs.2022.02.010. Epub 2022 Mar 3.
5
The CH1α domain of mucosal gp41 IgA contributes to antibody specificity and antiviral functions in HIV-1 highly exposed Sero-Negative individuals.黏膜 gp41 IgA 的 CH1α 结构域有助于 HIV-1 高度暴露的血清阴性个体中的抗体特异性和抗病毒功能。
PLoS Pathog. 2020 Dec 14;16(12):e1009103. doi: 10.1371/journal.ppat.1009103. eCollection 2020 Dec.
6
Neutralizing Antibodies Targeting HIV-1 gp41.靶向 HIV-1 gp41 的中和抗体。
Viruses. 2020 Oct 23;12(11):1210. doi: 10.3390/v12111210.
7
Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.gp41 MPER 在与 HIV-1 包膜预融合状态相关的脂双层上的拓扑分析。
Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22556-22566. doi: 10.1073/pnas.1912427116. Epub 2019 Oct 17.
8
The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.针对 gp41 膜近端外部区域 (MPER) 的 HIV 疫苗的开发:挑战与展望。
Protein Cell. 2018 Jul;9(7):596-615. doi: 10.1007/s13238-018-0534-7. Epub 2018 Apr 17.
9
In-Depth Analysis of Human Neonatal and Adult IgM Antibody Repertoires.深入分析人类新生儿和成人 IgM 抗体库。
Front Immunol. 2018 Feb 5;9:128. doi: 10.3389/fimmu.2018.00128. eCollection 2018.
10
Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target.膜近端外部区域的免疫学见解:人类免疫缺陷病毒1型主要疫苗靶点
Front Immunol. 2017 Sep 19;8:1154. doi: 10.3389/fimmu.2017.01154. eCollection 2017.

本文引用的文献

1
Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.识别1型人类免疫缺陷病毒gp120所需的广泛中和性免疫球蛋白G1 b12的分子特征
J Virol. 2003 May;77(10):5863-76. doi: 10.1128/jvi.77.10.5863-5876.2003.
2
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions.二硫键束缚的1型人类免疫缺陷病毒假病毒由氧化还原引发的感染
J Virol. 2003 May;77(10):5678-84. doi: 10.1128/jvi.77.10.5678-5684.2003.
3
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.HIV-1疫苗研发:受限肽免疫原显示出与抗HIV-1 gp41单克隆抗体的结合能力有所提高。
Biochemistry. 2003 Mar 25;42(11):3214-23. doi: 10.1021/bi026952u.
4
Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design.HIV-1抑制肽DP178中α-螺旋度的增强导致其对人单克隆抗体2F5的亲和力增加,但在体外未引发中和反应。对疫苗设计的启示。
J Biol Chem. 2002 Nov 29;277(48):45811-20. doi: 10.1074/jbc.M205862200. Epub 2002 Sep 16.
5
Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains.与睾酮结合的体外亲和力和特异性成熟的抗睾酮Fab的晶体结构。可变区内的微小结构变化导致亲和力提高。
J Biol Chem. 2002 Nov 15;277(46):44021-7. doi: 10.1074/jbc.M208392200. Epub 2002 Aug 23.
6
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge.产后暴露前和暴露后被动免疫策略:保护新生猕猴免受口服猿猴-人类免疫缺陷病毒攻击
J Med Primatol. 2002 Jun;31(3):109-19. doi: 10.1034/j.1600-0684.2002.01014.x.
7
Genetic evidence that interhelical packing interactions in the gp41 core are critical for transition of the human immunodeficiency virus type 1 envelope glycoprotein to the fusion-active state.有基因证据表明,gp41核心中的螺旋间堆积相互作用对于人类免疫缺陷病毒1型包膜糖蛋白转变为融合活性状态至关重要。
J Virol. 2002 Jul;76(14):7356-62. doi: 10.1128/jvi.76.14.7356-7362.2002.
8
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.利用针对gp41融合中间体的中和抗体剖析1型人类免疫缺陷病毒的进入过程。
J Virol. 2002 Jul;76(13):6780-90. doi: 10.1128/jvi.76.13.6780-6790.2002.
9
Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: effects of side-chain and backbone modifications and conformational constraints.HIV-1中和单克隆抗体2F5的gp41 ELDKWA表位中的结构-亲和力关系:侧链和主链修饰及构象限制的影响
J Pept Res. 2002 Jun;59(6):264-76. doi: 10.1034/j.1399-3011.2002.02988.x.
10
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.筛选出的与gp120-CD4-CCR5复合物结合的具有广泛交叉反应性的HIV-1中和人单克隆Fab。
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6913-8. doi: 10.1073/pnas.102562599. Epub 2002 May 7.